WuXi AppTec Acquires OXGENE to Increase Cell and Gene Therapy Offerings
02 Mar 2021 //
PHARMTECH
OXGENE Introduces TESSA Technology for Robust and Reproducible AAV Manufacture
22 Sep 2020 //
BUSINESSWIRE
02 Mar 2021 //
PHARMTECH
22 Sep 2020 //
BUSINESSWIRE
Market Place
Sourcing Support